July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Performance of a Novel OCT Segmentation Method for Determining Lesion Volume in the Assessment of a Non-Human Primate Model of Choroidal Neovascularization
Author Affiliations & Notes
  • Seth Eaton
    Ocular Services On Demand (OSOD), LLC, Madison, Wisconsin, United States
    EyeKor, Inc., Madison, Wisconsin, United States
  • Yijun Huang
    EyeKor, Inc., Madison, Wisconsin, United States
    Ocular Services On Demand (OSOD), LLC, Madison, Wisconsin, United States
  • Ronald P Danis
    EyeKor, Inc., Madison, Wisconsin, United States
    Ophthalmology & Visual Sciences, School of Medicine, University of Wisconsin - Madison, Madison, Wisconsin, United States
  • T. Michael Nork
    Ophthalmology & Visual Sciences, School of Medicine, University of Wisconsin - Madison, Madison, Wisconsin, United States
  • Carol Rasmussen
    Ocular Services On Demand (OSOD), LLC, Madison, Wisconsin, United States
    Ophthalmology & Visual Sciences, School of Medicine, University of Wisconsin - Madison, Madison, Wisconsin, United States
  • Hugh Wabers
    Ocular Services On Demand (OSOD), LLC, Madison, Wisconsin, United States
    EyeKor, Inc., Madison, Wisconsin, United States
  • Michael Neider
    Ocular Services On Demand (OSOD), LLC, Madison, Wisconsin, United States
    EyeKor, Inc., Madison, Wisconsin, United States
  • Brian J Christian
    Covance Laboratories, Madison, Wisconsin, United States
  • Menno Van Lookeren Campagne
    Genentech, Inc., South San Francisco, California, United States
  • Christopher J Murphy
    Ocular Services On Demand (OSOD), LLC, Madison, Wisconsin, United States
    Surgical & Radiological Sciences, School of Veterinary Medicine, University of California - Davis, Davis, California, United States
  • Footnotes
    Commercial Relationships   Seth Eaton, EyeKor, Inc. (C), Ocular Services On Demand, LLC (E); Yijun Huang, EyeKor, Inc. (I), EyeKor, Inc. (E), Ocular Services On Demand, LLC (C); Ronald Danis, EyeKor, Inc. (E), EyeKor, Inc. (I); T. Michael Nork, Ocular Services On Demand, LLC (C); Carol Rasmussen, Ocular Services On Demand, LLC (C); Hugh Wabers, EyeKor, Inc. (C), Ocular Services On Demand, LLC (C); Michael Neider, EyeKor, Inc. (C), Ocular Services On Demand, LLC (C); Brian Christian, Covance Laboratories (E); Menno Van Lookeren Campagne, Genentech, Inc. (E); Christopher Murphy, EyeKor, Inc. (I), Ocular Services On Demand, LLC (I), Ocular Services On Demand, LLC (C)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 1253. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Seth Eaton, Yijun Huang, Ronald P Danis, T. Michael Nork, Carol Rasmussen, Hugh Wabers, Michael Neider, Brian J Christian, Menno Van Lookeren Campagne, Christopher J Murphy; Performance of a Novel OCT Segmentation Method for Determining Lesion Volume in the Assessment of a Non-Human Primate Model of Choroidal Neovascularization. Invest. Ophthalmol. Vis. Sci. 2019;60(9):1253.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To compare the performance of a novel OCT segmentation method for determining lesion volume and fluorescein angiography (FA) in the assessment of eyes of non-human primates (NHP) with experimental CNV treated with intravitreal (IVT) Lucentis™ and those receiving IVT saline control.

Methods : Twenty eyes of 10 cynomolgus macaques with laser-induced CNV (9 laser areas/macula) were monitored using OCT and FA at 2- and 4-week time points following CNV induction. Ten eyes (5 animals) were treated with IVT Lucentis 2 days after the 2-week time point (LUC); the other 10 eyes (5 animals) were treated with IVT PBS (CTR). OCT volume scans were converted to DICOM format and 3 tissue boundaries were segmented using semi-automated software (EdgeSelect™; EyeKor, Inc.) including: the Inner Limiting Membrane (ILM), Bruch’s Membrane (BM), and the internal border of CNV lesions. Segmentation analyses were used to calculate the volumes of the CNV laser lesions (from the internal lesion border to BM), and total retinal volume (TRV; from ILM to internal lesion border). FA was scored using a semi-quantitative system to assign a leakage severity score (1-4) to each laser lesion.

Results : Three LUC eyes and 1 CTR eye were excluded after laser induction due to subretinal hemorrhage. Over the 2-4 week interval following induction, there was no significant difference (p=0.626) in mean % change in CNV volume in the 7 remaining LUC eyes (-41.002% ± 6.976) and the 9 remaining CTR eyes (-36.231% ± 6.510). There was a slightly significant difference (p=0.043) in mean % change in TRV between LUC eyes (-4.651% ± 0.946) and CTR eyes (-1.552% ± 0.978). During the same interval, the number of Grade 4 lesions on FA decreased by 100% in LUC eyes and 63% in CTR eyes.

Conclusions : OCT-derived CNV lesion volume measurements can provide valuable quantification data for structural retinal changes and generally correlate with FA leakage and change over time in untreated NHPs with laser-induced CNV. However, they are not necessarily superior to FA in predicting response to anti-VEGF treatment in this model. This may be due to higher amounts of subretinal fibrosis in laser-induced CNV lesions, yielding a discrepancy in OCT volume and FA leakage. CNV volume may be a more useful clinical endpoint to follow if treatment is administered at an earlier stage in the lesion development.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×